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Abstract 
The KCa3.1 channel (KCNN4) is an important modulator of microglia responses in rodents, 
but no information exists on functional expression in microglia from human adults. We 
isolated and cultured microglia (max 1 % astrocytes, no neurons or oligodendrocytes) from 
neocortex surgically removed from epilepsy patients and employed electrophysiological 
whole-cell measurements and selective pharmacological tools to elucidate functional 
expression of KCa3.1. The channel expression was demonstrated as a significant increase in 
the voltage-independent current by NS309, a KCa3.1/KCa2 activator, followed by full 
inhibition upon co-application with NS6180, a highly selective KCa3.1 inhibitor. A major 
fraction (79 %) of unstimulated human microglia expressed KCa3.1, and the difference in 
current between full activation and inhibition (∆KCa3.1) was estimated at 292±48 pA at -40 
mV (n=75), which equals at least 585 channels/cell. Serial KCa3.1 activation/inhibition 
significantly hyperpolarized/depolarized the membrane potential. The isolated human 
microglia were potently activated by LPS shown as a prominent increase in TNF-α 
production. However, incubation with LPS neither changed the KCa3.1 current nor the 
fraction of KCa3.1 expressing cells. In contrast, the anti-inflammatory cytokine IL-4 slightly 
increased the KCa3.1 current per cell, but since the membrane area also increased there was 
no significant change in channel density. A large fraction of the microglia also expressed a 
voltage-dependent current sensitive to the KCa1.1 modulators NS1619 and Paxilline and an 
inward-rectifying current with the characteristics of a Kir channel. The high functional 
expression of KCa3.1 in microglia from epilepsy patients accentuate the need for further 
investigations of its role in neuropathological processes.   
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Introduction 
Microglia are the resident immune cell of the human brain that serve an important role of 
continuously surveying the central nervous system (CNS) tissue and conduct maintenance 
work which for instance includes removing dead cells and tissue debris. However, microglia 
can, directly or indirectly, become excessively activated as characterized by release of a 
range of cytokines and growth factors that can be neurotoxic and cause tissue destruction for 
example in diseases like Alzheimer’s disease and multiple sclerosis. Microglia are therefore 
considered important target cells for therapeutic intervention in a number of 
neurodegenerative diseases (for recent reviews, see Kettenmann et al. (2011) and Michell-
Robinson et al. (2015)).  
Ion channels expressed on microglia cells may contribute to both restorative and degenerative 
processes, in particular via their influence on the microglia membrane potential, regulation of 
intracellular Ca2+ signaling, migration and volume regulation. The intermediate-conductance 
Ca2+-activated K+ channel, KCa3.1 (Ishii et al. 1997), which is a voltage-independent 
potassium channel encoded by KCNN4, is an important player in the regulation of immune 
responses mediated by T-cells (Ghanshani et al. 2000), B-cells (Wulff et al. 2004), and 
peripheral macrophages (Kang et al. 2014). KCa3.1 has also been reported to be expressed by 
rodent microglia (Ferreira et al. 2014; Kaushal et al. 2007; Khanna et al. 2001; Wong and 
Schlichter 2014) and implicated in a number of experimental animal models involving 
pathology in the CNS, e.g. ischemic stroke (Chen et al. 2011), traumatic brain injury (Mauler 
et al. 2004; Urbahns et al. 2003), spinal cord injury (Bouhy et al. 2011) and experimental 
autoimmune encephalitis (Reich et al. 2005). In rodent microglia in vitro cultures, KCa3.1 was 
originally shown to act in a pro-inflammatory manner participating in the respiratory burst 
process (Khanna et al. 2001) and pharmacological blocking of KCa3.1 by the selective KCa3.1 
inhibitor TRAM-34 gave reduced nitric oxide (NO) production following activation by 
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lipopolysaccharide (LPS) (Kaushal et al. 2007) or amyloid-β oligomers (AβO) (Maezawa et 
al. 2011). These effects could explain the in vivo neuroprotection of TRAM-34. However, in 
vitro experiments have also shown that, in addition to its classical pro-inflammatory role, 
KCa3.1 can also play a role in interleukin-4 (IL-4)-mediated activation of rat microglia 
(Ferreira et al. 2014), since significantly larger KCa3.1 currents could be measured after 
treatment with IL-4, which resulted in a TRAM-34-sensitive increased migratory potential 
(Ferreira et al. 2014).  
Despite the solid evidence from rodent microglia studies, functional expression and 
physiological/pathophysiological importance of KCa3.1 in adult human microglia has not yet 
been reported. Hitherto, the few functional studies using human microglia of fetal origin 
(abortions) or microglia isolated from removed neuronal tissue from epilepsy or cancer 
patients, have failed to reveal the presence of KCa3.1 channels (Bordey and Spencer 2003; 
McLarnon et al. 1997; Norenberg et al. 1994). However, based on immunohistology of post 
mortem tissue, Chen et al. (2015) recently showed a clear expression of KCa3.1 protein in the 
infarcted area in stroke patients. 
Since prominent differences in expression profiles and responses occur between rodent and 
human microglia (Smith and Dragunow 2014) the verification of functional expression of 
KCa3.1 in human microglia from adults is an important piece of missing evidence in the 
translational validation of KCa3.1 as a target for modulation of neuroinflammatory diseases. 
The access to neural tissue removed within a short timeframe allow production of primary 
cultures of microglial cells with high purity and relevant cellular physiological properties. In 
the present study, we conducted experiments on immunohistochemically characterized 
human microglia isolated from neocortex of adults undergoing therapeutic surgery due to 
medically intractable mesial temporal lobe epilepsy. We determined - by use of selective 
pharmacological tools combined with electrophysiology - the fraction of isolated human 
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microglia cells expressing functional KCa3.1, as well as the current density and the overall 
impact of the channel on the membrane potential in resting human microglia. We also 
investigated whether activation of these cells in vitro by IL-4 or LPS would change the 
functional expression of KCa3.1. We conclude that KCa3.1 constitute a major K+ conductance 
in isolated human neocortical microglia under all conditions investigated. We also found 
functional expression of the BK channel (KCa1.1) as well as an unidentified inward-rectifying 
K+ channel (Kir). 
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Materials and methods: 
Preparation of human microglia cultures 
The temporal neocortex was obtained from eight epilepsy patients undergoing anterior 
temporal lobectomies (ATL). During the operation part of the temporal neocortex was 
removed before performing an amygdalohippocampectomy. In all subjects the amygdala and 
hippocampus were determined to be the epileptogenic zone during the epilepsy surgery 
evaluation. Histopathological examinations of neocortex were normal in all subjects. Written 
informed consent was obtained from all patients before the surgery. All studies were in 
accordance with the protocol approved by the Rigshospitalet’s Ethical Committee in the 
Capital Region of Denmark (H-2-2011-104).  
The neocortex was immediately placed in high glucose Dulbecco's Modified Eagle Medium 
(DMEM) containing 1 mM pyruvate, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 mM 
glutamine on ice. The CNS resection was carefully cleaned from any blood residues and 
meninges. The tissue was cut into smaller pieces with a pair of scissors. Following a 
centrifugation step for 10 min at 400 x g the tissue was incubated with 0.05% trypsin-EDTA 
(Gibco) containing 0.15 KU/ml DNase (Sigma) for 15 min in a water bath at 37oC. The tissue 
was further dissociated using a Potter-Elvehjem homogenizer. Fetal bovine serum (FBS) was 
added to stop the trypsinization and the cell lysate was centrifuged for 10 min at 400 x g to 
remove the trypsin solution. The pellet was re-suspended in DMEM medium with above 
mentioned supplements as well as 5% FBS. The cell suspension was seeded at 2 x 105 
cells/ml in either four chamber LabTek glass slides (Fisher Scientific) for cell culture 
analysis, 24 well plates for molecular characterization, or 35 mm petri dishes containing 
round glass coverslips (Ø 3.5mm) for electrophysiological recordings. The cells were left to 
attach for 1-2 hours after which debris was removed by washing the bound cells twice with 
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fresh cell culture medium. The cells were allowed to recover for ≥ 5 days with the medium 
changed every 3-4 days.   
 
Immunocytochemistry and analysis of cell culture purity  
On day six post-isolation the cells were fixed in 4% paraformaldehyde in phosphate-buffered 
saline (PBS) for 20 min. Following 2 x 5 min of washing in PBS the cells were incubated 
with PBS containing 0.3% Triton X-100 for 20 min. This was followed by incubation in a 
blocking buffer consisting of 5% goat serum (Dako) in PBS for 20 min. The following 
primary antibodies were used to identify cells in the culture: rabbit anti-ionized calcium 
binding adaptor molecule 1 (Iba1; microglia; 1:1000; Wako Pure Chemical Industries) in 
combination with mouse anti-microtubule-associated protein 2 (MAP2; neurons; 1:1000; 
Sigma) and rabbit anti-glial fibrillary acidic protein (GFAP; astrocytes; 1:1000; Abcam) in 
combination with mouse anti-CC-1 (oligodendrocytes; 1:500; Abcam). A negative control 
was included where the primary antibody incubation step was omitted. The cells were 
incubated with the primary antibodies diluted in PBS containing 5% goat serum for 2 hours at 
room temperature. The cells were washed extensively for 3 x 5 min in PBS after which a mix 
of the following secondary antibodies was added: Alexa Fluor 555-conjugated anti-rabbit 
(1:400, Life Technologies) and Alexa Fluor 488-conjugated anti-mouse (1:400; Life 
Technologies) for 45 min at room temperature. The cells were again washed 3 x 5 min in 
PBS and the slides were finally mounted with Slow-Fade® Gold mounting medium 
containing DAPI nuclear dye (Life Technologies). Grayscale photographs of each staining 
were captured using an Axio Imager fluorescent microscope (Zeiss). Ten frames per marker 
and isolation session were captured for subsequent image analysis using the ImageJ software. 
Altogether the purity analysis was done on 3 isolation procedures (i.e. 30 frames per marker 
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altogether). The number of cells stained with each specific marker in each frame was counted 
and expressed as a percentage of the number of DAPI+ nuclei in that same frame.   
 
Quantification of pro-inflammatory cytokine expression following LPS stimulation 
On day six post-isolation the microglia were exposed to 0, 0.3, 1 or 10 ng/ml 
lipopolysaccharide (LPS) for four hours. Two replicates were included per concentration. 
After the stimulation the cell culture medium was collected and stored at -80oC until the 
ELISA analysis could be performed. The amount of TNF-α released by microglia was 
analyzed using a Human TNF-α ELISA Ready-SET-GO!® (eBiosciences) according to the 
manufacturer’s instructions. 
The gene expression of the pro-inflammatory cytokines interleukin-6 (IL-6), interleukin-1 
beta (IL-1β) and TNF-α was quantified using quantitative real-time PCR (qPCR). Following 
exposure to 0.3 ng/ml LPS for four hours the stimulated and unstimulated control cells were 
washed in PBS and lysed in RLT buffer (Qiagen). The total ribonucleic acid (RNA) was 
subsequently extracted using the RNeasy Mini Kit (Qiagen) as per manufacturer’s 
instructions. The optional DNase treatment step was included in the procedure. The extracted 
RNA was reverse transcribed into cDNA using the ImProm-IITM Reverse Transcriptase 
(Promega). For qPCR experiments a reaction mix of 20 µl per sample containing 10 µl IQ 
SYBR Green master mix (Bio-Rad Laboratories), 4.7 µl RNase free water, 0.15 µl of each 
primer and 15 µl cDNA template was prepared. The following primers were used (Nhu et al. 
2010): TNF-α Fw: 5′-CCC AGG GAC CTC TCT CTA ATC A-3′ Re: 5′-GCT TGA GGG 
TTT GCT ACA ACA TG-3′, IL-1β Fw: 5′-AAA TAC CTG TGG CCT TGG GC-3′ Re: 5′-
TTT GGG ATC TAC ACT CTC CAG CT-3′, IL-6 Fw: 5′-GTA GCC GCC CCA CAC AGA-
3′ Re: 5′-CAT GTC TCC TTT CTC AGG GCT G-3′, GAPDH Fw: 5′-GGA TGA TGT TCT 
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GGA GAG C-3′ Re: 5′-GGT ATC GTG GAA GGA CTC-3′. The following PCR cycling 
conditions were used: 94oC for 10 min followed by 40 cycles of 94oC for 30s, 60oC for 45s 
and 72oC for 90s. The concluding melt curve (50oC to 94oC) analysis showed a single PCR 
product which was also confirmed using gel electrophoresis. Relative gene expression was 
calculated using the 2-∆∆Ct method. All samples were run in duplicates and were normalized 
against the expression levels of the housekeeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). 
 
Microglia patch-clamp electrophysiology  
To induce activation in microglia they were treated for 2-4 days with either 20 ng/ml 
interleukin-4 (IL-4; PeproTech) or 100 ng/ml LPS (Sigma) diluted in the regular cell culture 
medium. Age matched unstimulated microglia were treated exactly the same way, only no 
stimulating reagent was added to the regular cell culture medium. Coverslips from the three 
different dishes were transferred to a chamber mounted on the stage of an inverted 
microscope. The cells were superfused with extracellular saline (in mM: 126 Na-gluconate, 
14 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES; pH adjusted to 7.4 with NaOH) at a rate of 1-
2 ml/min using a gravity-driven system. The pipette solution (in mM: 110 K-gluconate, 15 
KCl, 4.3 CaCl2, 1 MgCl2, 5 EGTA, 15.6 KOH, 2 MgATP, 10 HEPES; pH 7.2) was adapted 
from Ferreira et al. (2014) and contained ~1 µM free Ca2+  as calculated by the Maxchelator 
program (http://maxchelator.stanford.edu/webmaxc/webmaxcE.htm). The pipettes were 
created from borosilicate glass (Vitrex) using a DMZ-Universal puller (Zeitz-Instruments 
GmbH) and had a resistance of 3-5 MΩ. Upon establishment of the whole-cell configuration, 
a voltage ramp protocol (–120 to 30 mV in 150 ms) was applied every 5 s from a holding 
potential of -90 mV. Series resistance compensation and fast and slow capacitance 
cancellations were updated at every application of the protocol in order to track the stability 
Page 10 of 51
John Wiley & Sons, Inc.
GLIA
11 
 
of the recording. The Cslow parameter (pF/cell) measured immediately after whole-cell 
establishment was used to estimate the cell to cell variability in sizes, based on the value of 
specific capacitance of 1 µF/cm2 membrane area.  
For the current-clamp experiments an extracellular saline with high chloride concentration 
was used (in mM: 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES; pH adjusted to 7.4 with 
NaOH) and the pipette solution contained in mM: 109 KCl, 5.2 CaCl2, 1.4 MgCl2, 10 EGTA, 
31 KOH, 10 HEPES; pH 7.2 giving a calculated free [Ca2+] of 0.2 µM according to 
Maxchelator, see above). All recordings were conducted at room temperature using a HEKA 
EPC-9 amplifier and the PULSE software (HEKA Elektronik). 
 
Pharmacological tool compounds 
The KCa3.1/KCa2 activator NS309 (6,7dichloro-1Hindole-2,3-dione 3-oxime), the KCa3.1 
inhibitor NS6180 (4-[[3-(trifluoromethyl)phenyl]methyl]-2H-1,4–benzothiazin-3(4H)-one) 
and the KCa1.1 activator NS1619 (1-(2′-hydroxy-5′-trifluoromethlphenyl)-5-trifluoromethyl-
2(3H)benzimidazolone) were synthesized according to previous descriptions (Olesen and 
Waetjen 1993; Strobaek et al. 2013; Strobaek et al. 2004). The BK channel inhibitor Paxilline 
(a tremorgenic alkaloid (Knaus et al. 1994)) was purchased from Sigma-Aldrich. All the 
compounds were dissolved in dimethyl sulfoxide (DMSO) to a stock concentration of 10 
mM, aliquoted and stored at -20oC. On the day of experiment the compounds were diluted in 
the extracellular saline to the final concentrations. The highest concentration of DMSO used 
in our experiments was 0.1 %. Control experiments showed that the microglia currents were 
unaffected by this concentration of DMSO (data not shown).  
 
Statistical analysis 
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All data are given as means ± SEM unless indicated otherwise. For TNF-α release 
experiments the number of observations (n) means the number of replicates in one 
experiment; for the patch clamp experiments (n) means the number of individual cells 
measured. Data sets were analyzed for statistically significant differences (p ˂ 0.05) between 
treatments, time points or concentrations using a t-test or a one-way ANOVA with a 
Newman-Keuls post-hoc test, unpaired or paired test as appropriate in each situation. For 
changes in proportion between groups a chi-square (χ2) test was used.  
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Results 
Isolation and culturing of human microglia 
In order to evaluate the expression of KCa3.1 channels in adult human microglia, we first 
needed to establish an isolation procedure to obtain high purity in vitro cultures. Purity and 
viability of the cells six days following the isolation procedure were investigated using 
immunocytochemistry (Fig. 1A, B). We found that the cultures contained 92% pure microglia 
(Iba1), 1% astrocytes (GFAP) and no oligodendrocytes (CC-1) or neurons (MAP2) (Fig. 1C). 
Seven percent of the DAPI+ cells remained unstained. As seen from the figure the Iba1+ 
microglia are large cells (notably bigger than isolated rat microglia) and exhibit various 
morphologies but typically had a larger cell body and shorter/thicker processes compared to 
the few astrocytes that survived the isolation. These characteristics were used in the selection 
of cells to patch in the electrophysiological experiments.  
We next established that the cells remained functional in culture. Different concentrations of 
LPS (0, 0.3, 1.0 and 10 ng/ml) were added to the microglia culture medium which was then 
analyzed for released amounts of the pro-inflammatory cytokine TNF-α four hours later. No 
detectable levels of TNF-α could be measured in the absence of LPS indicating that the 
microglia, although originating from an adult human brain and despite the isolation 
procedure, remained in an inactivated state with respect to TNF-α production. Addition of 0.3 
ng/ml LPS caused a significant increase of TNF-α (p<0.01) to a final concentration of 400 
pg/ml. Higher concentrations of LPS, 1.0 and 10 ng/ml respectively, did not significantly 
result in additional elevated levels of TNF-α compared to the lower LPS concentration (Fig. 
1D). Furthermore, treatment of the microglia cells in vitro with 0.3 ng/ml LPS resulted in a 
significant increase in the gene expression of the pro-inflammatory cytokines TNF-α and IL-
1β (p<0.05) and a trend towards an increase in IL-6 expression (p = 0.06) (Fig. 1E). These 
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results made us confident that the isolation procedure yielded a pure and functional microglia 
culture to be used in the time span of 5-9 days in the current experimental series. We 
furthermore noted that the human microglia did not exhibit noteworthy proliferation in this 
period.  
 
Human microglia express several types of Ca2+-activated K+ channels  
The above mentioned morphological characteristics guided the selection of cells for whole 
cell patch clamp experiments and the visually observed large size of the cells were confirmed 
by membrane capacitance measurements (23.5 ± 7.6 pF; n = 19). We next addressed whether 
the human microglia cells express functional KCa3.1 channels. For these experiments a set of 
intracellular (pipette) and extracellular salines with reduced Cl- concentrations were used in 
order to minimize possible currents through Cl- channels and electrogenic anion transporters, 
and with a relatively high free intracellular Ca2+ concentration (~1 µM) in order to enhance 
the chances of detecting Ca2+-activated K+ currents. Whole-cell currents were elicited by 
applying voltage ramps of 150 ms duration starting at -120 mV and ending at 30 mV. Since 
KCa3.1 are K+ selective channels that are not gated by voltage they mediate currents that are 
essentially linearly dependent on voltage in the range of -90 (= EK) to 0 mV. Fig. 2A shows 
the current-voltage (IV) relationships recorded from a microglia cell before and after 
application of the highly selective and potent (IC50 = 9 nM) KCa3.1 inhibitor NS6180 at a 
concentration of 1 µM (Jenkins et al. 2013; Jorgensen et al. 2013; Strobaek et al. 2013) (see 
also Supplementary Table 1). The complete inhibition of KCa3.1 (> 99 % as calculated from 
the Hill equation) strongly reduced the slope of the IV curve, and caused a distinct 
depolarizing shift in the reversal potential from -74 mV to -13 mV consistent with a 
decreased total K+ conductance. The difference IV curve conforms well to the predicted 
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KCa3.1 IV relationship with a reversal potential close to EK (-89 mV). This experiment shows 
that the linear current in this cell is mainly mediated by KCa3.1 without significant 
contribution from KCa2 channels which are insensitive to NS6180 (for quantification of 
KCa3.1, see later). As shown in Fig. 2B (different cell) the control IV relationship in some 
cells crossed the voltage axis at a more depolarized level (in this case at ~ -55 mV). This is 
attributable to the combination of a relatively low KCa3.1 expression/activation possibly 
combined with some contribution of background cation and/or residual Cl- conductances with 
equilibrium potentials close to zero or above. Upon application of increasing concentrations 
of the KCa3.1/KCa2 activator NS309, however, a clear and concentration dependent increase 
in the linear current component occurred and the zero current potential gradually shifted 
towards EK, reflecting an increasingly dominating K+ conductance in this cell. Fig. 2C shows 
the current from this cell analyzed at -40 mV as a function of time with the periods and 
concentrations of NS309 indicated by the bars above. The average equilibrium responses vs. 
concentrations (n = 7; Fig. 2D) were fitted to a Hill-equation and gave an EC50 value of 44 
nM, a value close to the observed EC50 value for NS309 activation of human KCa3.1 channels 
expressed in HEK-293 cells recorded under identical conditions (20 nM, see Supplementary 
Fig. 1). The concentration-response plot also shows that a near maximal response to NS309 is 
obtained at a concentration of 500 nM, which we continued to use for quantification 
throughout the rest of the study.  
The KCa3.1 current was sometimes recorded in combination with a putative K+ current with 
outward-rectifying characteristics (Kor) seen as an increased slope of the IV curve at positive 
potentials, or an inward-rectifying current (Kir) causing an abrupt conductance increase at 
potentials negative to EK (for a summary of IV phenotypes of the microglia population, see 
Supplementary Fig. 2). Fig. 3 shows a representative recording from a microglia cell 
expressing both KCa3.1 and Kor as evident from the IV relationships in panel A. The analysis 
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was in this case performed at two different voltages: -40 mV (KCa3.1) and +30 mV (sum of 
KCa3.1 and Kor). Following the establishment of a baseline (with a small but stable current 
run down at +30 mV), 500 nM NS309 was applied and a clear increase in current size could 
be seen at both -40 mV and +30 mV (Fig. 3A, C). Upon application of NS6180 the current at 
-40 mV was strongly reduced, proving that the current also in this cell was carried by KCa3.1 
(NS6180 exerts no effect on KCa2 at this concentration, see Strobaek et al. (2013)). After 
having removed the KCa3.1 current by NS6180 the outward rectification of the current 
remaining positive to 0 mV now became more clear (Fig. 3B). In rat microglia the voltage-
dependent outward-rectifying K+ current has been described as being mediated by various Kv 
channels including Kv1.3 (Jou et al. 1998) (antibody staining only); (Fordyce et al. 2005; 
Khanna et al. 2001). We were curious to reveal what mediates this current in human 
microglia, especially since a large proportion of cells (80%) actually exhibit a discernible Kor. 
We exploited the fact that NS6180 does not readily wash off from the KCa3.1 channel at a 
concentration of 1 µM and this particular experiment was therefore continued by changing 
directly into a saline containing the KCa1.1 selective activator NS1619 (10 µM). This resulted 
in a prominent current increase at +30 mV, whereas the current at -40 mV remained 
negligible (Fig. 3B, C). Following co-addition of the selective KCa1.1 inhibitor Paxilline the 
current at +30 mV was fully inhibited. Since Kor was sensitive to NS1619 and completely 
inhibited by Paxilline in nine experiments, we conclude that the predominant voltage-
dependent outward current in human microglia is mediated by KCa1.1. Note that this finding 
is different from our identical experiments with microglia isolated from rat pups, which 
clearly express a Kv-type K+ current activating at negative membrane potentials, see 
Supplementary Fig. 3. In contrast, for the Kir component also faintly co-expressed with 
KCa3.1 in some cells, we have no clue to the molecular identity and we did not characterize it 
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further in any detail. We did, however, ascertain that NS309 and NS6180 did not change this 
component (see Supplementary Fig. 4). 
 
Quantification of functional KCa3.1 channels in unstimulated microglia cells  
In order to quantify the amplitude of the maximally attainable KCa3.1 current we 
systematically measured the responses to sequential application of NS309 and NS6180 (as 
shown in Fig. 3) in a large number of cells and we defined the ∆KCa3.1 current as the 
difference in current size between full activation (NS309) and full block (NS6180). A cell 
with a ∆KCa3.1 current difference of ≥ 20 pA was considered to express functional KCa3.1 
channels, whereas cells with a current change ˂ 20 pA were considered a non-expresser (see 
below and Discussion for further elaboration). Typical examples of unresponsive vs 
responsive cells can be seen in Fig. 4A and Fig. 4Ci. A total of 95 human microglia cells were 
tested out of which 75 cells (79%) turned out to be responsive and 20 cells (21%) 
unresponsive to NS309 and NS6180 (Fig. 4B). A quantitative assessment was conducted of 
the cells responsive to KCa3.1 pharmacology: On average this population exhibited a highly 
significant increase in the KCa3.1 current following application of NS309 (p<0.001) (Fig. 4Ci, 
Cii). Similarly there was a highly significant decrease of the KCa3.1 current following co-
application of NS309 and NS6180 (p<0.001), reaching a value of -13 ± 8 pA, which was 
furthermore also significantly lower than the initial baseline current (p<0.05). We never 
observed cells where NS309-facilitated currents could not be inhibited by NS6180 which 
rules out the possibility that KCa2 channels could have contributed significantly to the total 
voltage-independent current in these cells. On average the human microglia cells displayed a 
∆KCa3.1 current of 292 ± 48 pA (n = 42), which can be converted to total KCa3.1 single cell 
chord conductance, G: 
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G = ∆KCa3.1/(Vm – EK) = 292 * 10-12 A/0.05 V = 5.84 nS 
Assuming a single channel chord conductance, g = 10 pS at room temperature and near 
physiological intracellular and extracellular K+ concentrations (Christophersen 1991; Sauve 
et al. 1986) and that full activation by NS309 results in an open state probability (Po) of 1, 
this conductance can be converted to an absolute number of expressed functional channels 
(N) per microglia cell: 
N = G/g = 5840 pS per cell/10 pS per channel = 585 channels/cell1 
Note, however, that since the effect of NS309 has not been investigated in single channel 
recordings, the Po(max) = 1 is a theoretical limiting assumption, and the calculated channel 
number per cell is therefore an average minimum estimate.  
We wanted to elucidate the impact of KCa3.1 activation and inhibition on the microglia 
membrane potential, which in many cases is the immediate mediator of down-stream effects 
of KCa3.1 activation under physiological/pathophysiological conditions. Thus, we performed 
current-clamp experiments (no applied current) using basically the same experimental 
paradigm as above. For these experiments, however, we used extracellular and intracellular 
salines with near physiological [Cl-] concentrations, and a pipette solution which was 
buffered closer to the expected level of intracellular “resting” free Ca2+. Fig. 4Di shows a 
typical example of a membrane potential vs. time recording. Upon stabilization the 
membrane potential fluctuated around a value of -16 mV. Application of 500 nM NS309 
immediately hyperpolarized the cell to -77 mV and the fluctuations were much reduced as 
expected from the increased KCa3.1 open state probability in the presence of NS309 
combined with the much reduced driving force on the K-ion. Co-application with NS6180 
resulted in a depolarization to -21 mV. The quantification and summary statistics are 
illustrated in Fig. 4Dii (n = 7). In conclusion, the degree of activation of the KCa3.1 channel 
expressed in human microglia cells exerts a profound effect on the membrane potential and is 
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therefore concluded to represent a significant hyperpolarizing reserve in human microglia. In 
contrast, application of NS1619 at 10 µM elicited no hyperpolarization, in accordance with 
the strong and fast deactivation of the KCa1.1 channel at negative membrane potentials 
(results not shown).  
 
Quantification of KCa3.1 functional expression in LPS and IL-4 stimulated microglia 
All experiments conducted so far were performed on the unstimulated and supposedly 
‘resting’ human microglia, but we were also interested in investigating whether the 
expression and/or function of KCa3.1 would change upon in vitro activation by standard pro-
inflammatory (LPS) and anti-inflammatory (IL-4) treatments as has been demonstrated for 
rodents. The microglia cells were stimulated for 2-4 days with either 100 ng/ml LPS or 20 
ng/ml IL-4 after which the electrophysiological measurements were performed. Since the 
treatments were conducted over a few days in vitro, we tested whether the baseline current, 
the current following activation with NS309, as well as the ∆KCa3.1 current remained stable 
over days in vitro. Indeed, in unstimulated cells no changes in current pre- or post-NS309 
application or ∆KCa3.1 could be seen between day 5 (the earliest day the cells were used post-
isolation) up until day 9 (Supplementary. Fig. 5A; p>0.05). We did also not observe any time 
dependent changes in current amplitudes for either IL-4 or LPS (Supplementary Figs 5B and 
5C) over the 4 days in which the cells were stimulated (p>0.05). This is also in line with 
previous studies from rats, where the KCa3.1 current amplitude did not change following 
treatment with IL-4 over 6 treatment days in vitro (Ferreira et al. 2014). Hence, the results 
shown and discussed in the following are exclusively due to the treatment effects, and not 
influenced by a time overlay. 
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A typical example of an IV profile of a microglia cell treated with either IL-4 or LPS and 
with a dominant KCa3.1 current can be seen in Figs. 5Ai and 5Bi respectively. Quantitative 
analysis of the currents pre- and post-NS309 as well as after the application of NS6180 was 
conducted and plotted as individual data points for the respective treatments (Figs. 5Aii and 
5Bii). Figs. 5Aiii and 5Biii show the average current for each treatment group. In both the 
microglia population activated by IL-4 and the population activated by LPS a clear and 
significant increase in the current was observed in response to NS309 (p<0.001). The 
addition of NS6180 substantially inhibited the current in both cases (p<0.001) even further 
below the baseline current (p<0.05). In summary, this means that activated cells, similar to 
unstimulated microglia, respond significantly to KCa3.1 pharmacology. 
As described above (Fig. 4B), 79% of our unstimulated microglia population expressed 
functional KCa3.1 channels. This proportion did not change significantly when the cells were 
stimulated with either IL-4 or LPS where 86% (n=38) and 73% (n=42) of the recorded cells 
expressed functional KCa3.1 channels, respectively (Fig. 6A; p=0.35). Based on the IV 
phenotyping the proportion of cells expressing Kir and Kor currents also remained constant, 
(see Supplementary Figs 2B and 2C). Further investigation of the current amplitude 
differences between unstimulated and stimulated microglia revealed that IL-4 treated cells 
had a significantly greater ∆KCa3.1 window compared to unstimulated cells (Fig. 6B; 
p<0.01). The difference between full activation and full block in these cells was measured to 
be 607 ± 88 pA compared to a ∆KCa3.1 current of 292 ± 48 pA in unstimulated cells and 478 
± 102 pA in LPS-treated cells. However, it was also noted that microglia exposed to IL-4 had 
a significantly greater cell membrane surface area (measured as cell capacitance) compared to 
both unstimulated cells (p<0.001) as well as LPS-treated cells (p<0.01). There was no 
difference in membrane capacitance between unstimulated and LPS treated microglia (Fig. 
6C). However, when the current for each individual cell was normalized against its cell size, 
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the current difference between unstimulated microglia and microglia exposed to IL-4 
disappeared (Fig. 6D; p>0.05). This indicates that IL-4 treated cells have the same number of 
KCa3.1 channels per membrane area and that the larger ∆KCa3.1 current is due to the greater 
cell size rather than having additional channels present per membrane area.  
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Discussion 
We have established methods for isolation, cultivation and in vitro maintenance of highly 
purified human microglia cultures essentially devoid of neurons and other glial cells, by using 
adult brain tissue surgically resected from patients with treatment-resistant epilepsy. The 
microglial source was neocortical tissue removed in the surgery to get access to the epileptic 
foci in the hippocampus. This tissue showed no discernable histopathology and was therefore 
considered relatively unaffected by the patient´s epilepsy and potentially a reference for 
future studies with foci-derived microglia or microglia from established neuroinflammatory 
diseases. Experimental support for considering these microglia as resting cells were lack of 
basic TNF-α release and negligible gene expression levels of TNF-α and IL-1β combined 
with a massive upregulation and secretion upon challenge with the standard pro-
inflammatory molecule LPS, a response in accordance with the expression of toll-like 
receptors (TLRs) on prenatal human microglia (Jack et al. 2005). Since K+ channels, in 
particular the KCa3.1 channel, are important in rodent microglia and often upregulated during 
activation, a primary goal of this study was to make a quantitative exploration of the basic 
functional expression of KCa3.1 in these adult human microglia cells compared to similar 
measurements reported in the literature using rodent microglia. Furthermore, we also aimed 
at exploring whether standard pro- and anti-inflammatory stimulations in vitro might 
influence the expression level. 
 
Unstimulated human microglia cells  
We found that a large fraction (79 %) of the microglia cells expressed KCa3.1, usually as the 
predominant K+ conductance in the physiological membrane potential range. We quantified 
this functional expression by calculating the difference in current between full 
pharmacological activation by NS309 and full inhibition by NS6180. This ∆KCa3.1 value 
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allowed clear distinction from the expression of other major ion conductances, such as a Kir 
channel (unknown molecular background) and the Kor, which were identified as KCa1.1 by its 
voltage-dependence and its pharmacology. The ∆KCa3.1 value was found on average to 
amount to 292 pA at -40 mV, which we - provided certain reasonable assumptions, see the 
Results section - estimated to be equivalent to a minimum average number of 585 functional 
KCa3.1 channels per cell.   
The functional impact of KCa3.1 activation/inhibition was directly confirmed by current 
clamp measurements: From an average resting membrane potential of -24 mV all cells 
responded with a distinct hyperpolarization upon NS309 application and with an ensuing 
depolarization by adding NS6180. Thus, activation/inhibition of KCa3.1 strongly influences 
the membrane potential of unstimulated human microglia cells. This is considered a 
significant finding, since many down-stream functions of KCa3.1 activation (e.g. regulation of 
transmembrane Ca2+-flux) are mediated via changes in the membrane potential.  
 
IL-4 and LPS stimulation  
With KCa3.1 established as a major K+ channel in the untreated microglia, we focused on 
possible changes in functional expression level upon pro-inflammatory (LPS) respectively 
anti-inflammatory (IL-4) stimulations: There was no significant change in the fraction of 
KCa3.1 expressing cells compared to the resting condition (79 %) by either treatment (84% 
for IL-4, 73 % for LPS). The average ∆KCa3.1 current in the KCa3.1 expressing fraction of the 
IL-4 treated cells were significantly increased to 207 % of the unstimulated current level, 
which is equivalent to an increase in average channel numbers from 584 to 1209 channels per 
microglia cell. In contrast, no significant change was observed in the LPS treated cells. 
Interestingly, a closer analysis revealed that the IL-4 stimulated cells had significantly 
increased input capacitance (30 pF) compared to unstimulated cells (20 pF), reflecting an 
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increase in the cell membrane area as a result of the stimulation, whereas the recorded 
capacitance (22 pF) of LPS stimulated cells was not significantly different from that of the 
resting cells. Using the standard value for specific cell membrane capacitance (1 µF/cm2) the 
channel density per unit membrane area was thus calculated at 0.14 channels/µm2 
(unstimulated cells), 0.22 channels/µm2 (IL-4 stimulated cells), and 0.20 channels/µm2 (LPS), 
respectively. As these numbers are not significantly different, we conclude that in vitro 
treatment with neither IL-4 nor LPS changed the density of KCa3.1 channels on the human 
microglia cells.  
 
Comparison to other studies 
As previously mentioned there are relatively few reports on the functional expression of K+ 
channels from human microglia cells, in particular from adults. Bordey and Spencer (2003) 
performed patch clamp studies on putative microglia directly in slices from hippocampi 
isolated from epileptic or brain tumor patients, and only found cells with very low or even 
lack of functional activity of any ion channels at negative membrane potentials (extremely 
low total input conductance, 0.28 nS, put into perspective by comparison with the specific 
KCa3.1 mediated conductance of 5.84 nS found in our study). At positive potentials a voltage 
and Ca2+-activated K+ channel with high unitary conductance was identified, which clearly 
was due to KCa1.1. Norenberg et al. (1994) also used an adult microglia preparation, and 
observed currents consistent with Nav channels followed by an outward-rectifying 
conductance depending on intracellular K+ and with the general characteristics of a Kv 
channel. No K+ conductance with KCa3.1 properties was identified. McLarnon et al. (1997) 
investigated microglia from human foetuses, and found evidence of A-type Kv currents in 
unstimulated cells, and, upon stimulation with the pro-inflammatory cytokine IFN-ɤ, another 
outward-rectifying K+ conductance with all biophysical characteristics consistent with 
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KCa1.1. Again, however, no indication of currents attributable to KCa3.1 was noted. Recently, 
Chen et al. (2015) reported, as part of their studies on microglia in stroke, expression of K+ 
channels by immunohistochemistry on post mortem human tissue, and found evidence for 
presence of KCa3.1 and Kv1.3 protein on microglia/macrophages in the infarcted area of 
patients, whereas no protein was detected in non-infarcted areas. No functional studies were 
performed.  
A quite extensive body of literature exists on the basic expression of KCa3.1 as well as other 
K+ channels in primary or acutely isolated rodent microglia under different stimulation 
paradigms in vitro. A consistent finding across studies suggest expression of KCa3.1, Kir2.1, 
and Kv1.3 (Chen et al. 2015; Ferreira et al. 2014; Ferreira et al. 2015; Kaushal et al. 2007) 
with some reports also being consistent with functional expression of KCa2.3 (Schlichter et al. 
2010; Siddiqui et al. 2014). While our study clearly confirmed functional expression of 
KCa3.1 in the human microglia and also a Kir current (possibly attributed to Kir2.1), it is 
noteworthy that we found no evidence for functional expression of Kv1.3 (or any other Kv 
channel), since the measured Kor currents were sensitive to both NS1619 and Paxilline and 
therefore attributable to KCa1.1. It may be argued that the ramp protocol used is not optimal 
for detection of an inactivating channel like Kv1.3, and that we therefore have underestimated 
or even missed it. However, control experiments using the same voltage-clamp ramp protocol 
with rat microglia clearly showed the Kv1.3 current. We also found no evidence for a major 
contribution of KCa2 channels, since NS6180 (no effect on KCa2.3 at 1 µM) essentially 
eliminated the NS309 augmented voltage-insensitive K+-current.  
Focusing specifically on the functional expression level of KCa3.1 in microglia from rat pups, 
(Ferreira et al. 2014) reported a basic NS309/TRAM-34 defined KCa3.1 conductance (using a 
protocol resembling the ∆KCa3.1 method used here) of 1.7 pA/pF in the unstimulated cell and 
39 pA/pF (current measured at +80 mV) upon stimulation with IL-4. For comparison, a 
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recalculation of our corresponding data from the human microglia yields ~49 pA/pF for the 
unstimulated cells and ~74 pA/pF for the IL-4 stimulated cells. Using acutely isolated 
microglia from mice, Chen et al. (2015) also reported a TRAM-34 defined KCa3.1 
conductance of 20 pS/pF from acutely isolated and unstimulated cells, as well as values of 72 
pS/pF from microglia isolated from a MCAO induced infarct, and 84 pS/pF from microglia 
isolated upon intracerebroventricular LPS injection. In comparison, our values expressed in 
the same units are 285 pS/pF for unstimulated cells and 436 pS/pF respectively 410 pS/pF for 
IL-4 and LPS stimulated cells. The unstimulated human microglia cells from this study thus 
expressed substantially higher KCa3.1 currents than both unstimulated primary rat microglia 
and acutely isolated mouse microglia (10-30 times), and were furthermore on par with the 
expression levels obtained with the various in vitro/in vivo stimulation procedures applied 
with the rodent microglia (1-3 times).  
In conclusion, we have found a very substantial functional expression of KCa3.1 channels in 
microglia from adult epilepsy patients. It is quite remarkable that the level is as high - or even 
higher - than observed in LPS or otherwise experimentally activated rodent microglia. It is 
also noteworthy that the KCa3.1 expression could not be increased further by standard pro- or 
anti-inflammatory treatments as has repeatedly been demonstrated in the literature for rodent 
microglia. We suggest that these human microglia cells are already maximally primed with 
respect to KCa3.1 expression. These findings may raise several important questions for future 
studies; for example whether this high KCa3.1 expression and functional activity reflects the 
normal situation in healthy resting adult microglia or whether the non-pathological 
neocortical tissue is somehow influenced by the epileptic condition of the patients (or by their 
medication history), thereby causing a microglia phenotype with a high KCa3.1 level. 
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Footnotes 
1 It is worth noting that our criterion for a KCa3.1 expressing cell is a ∆KCa3.1 > 20 pA, which 
is equivalent to 400 pS. Microglia cells expressing less than 40 KCa3.1 channels have 
therefore been categorized as non-expressers in this study. 
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Tables 
Supplementary Table 1. The name, structure and main action of the compounds used in this 
study. 
Compound Structure Type References 
NS309 
 
KCa3.1 activator 
KCa2 activator 
Strobaek et al. 2004 
NS6180 
 
KCa3.1 inhibitor 
Jorgensen et al. 2013 
Strobaek et al. 2013 
Jenkins et al. 2013 
NS1619 
 
KCa1.1 activator Olesen et al. 1994 
Gribkoff et al. 1996 
Paxilline 
 
KCa1.1 inhibitor Strobaek et al. 1996 
Gribkoff et al. 1996 
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Figure legends 
Figure 1. The human microglia culture is pure and responsive to stimulation with LPS. 
Photomicrographs of the cell culture with (A) human microglia stained for Iba1 in red and 
(B) astrocytes stained for GFAP in green 6 days post-isolation. The boxes in the bottom right 
corners show a microglia and an astrocyte, respectively, at higher magnification. 
Counterstaining of DAPI+ nuclei can be seen in blue. A-B (including insert): Scale bars: 50 
µm. (C) Quantitative purity analysis of the human microglia cultures (n = 3) at 6 days post-
isolation. In addition to Iba1 and GFAP the cultures were stained for neurons (MAP2) and 
oligodendrocytes (CC-1) and stained cells were expressed as a percentage of the total amount 
of DAPI+ nuclei. (D) Quantification of TNF-α release following incubation with LPS (0.3, 1, 
and 10 ng/ml) for four hours shows a significant response at all LPS concentrations tested. C-
D: Bars represent mean ± SEM; D: unpaired one-way ANOVA ** p<0.01, *** p<0.001. (E) 
Gene expression analysis of pro-inflammatory cytokines following stimulation with LPS for 
four hours. Bars represent mean ± SEM; unpaired t-test * p<0.05, ** p<0.01. 
 
Figure 2. Human microglia express KCa3.1 channels sensitive to the inhibitor NS6180 and 
the activator NS309. (A) Current-voltage (IV) plot from a human microglia cell obtained 
during a whole-cell recording in voltage-clamp mode. The currents were elicited by applying 
voltage ramps (from -120 mV to 30 mV in 150 ms) every 5 seconds from a holding potential 
of -90 mV. The current traces appear voltage-independent (linear) and were obtained before 
(Control) and after the application of the KCa3.1 selective inhibitor NS6180 (1 µM). The 
KCa3.1 IV curve (red trace) was obtained by subtracting the NS6180 trace from the Control 
trace. EK indicates the calculated equilibrium potential for K+ (-90 mV) with the salines used 
(see method section). (B) IV plot showing the effect of increasing concentrations of the 
Page 34 of 51
John Wiley & Sons, Inc.
GLIA
35 
 
KCa3.1 activator NS309. The individual current traces were obtained before or after 
application of NS309 in the concentrations indicated to the right of the traces. (C) Time 
course of the experiment in (B) plotted as the current amplitude measured at -40 mV as a 
function of time. NS309 was present in the extracellular saline as indicated by the bars. (D) 
Averaged concentration-response plot for NS309. For each cell (n=7) the responses to NS309 
were fitted to a Hill equation (EC50 values in the individual cells ranged from 16 to 85 nM) 
and normalized to the fitted current maxima. These normalized data points were averaged and 
plotted in (D) where each point represent the mean ± SD from 4-5 cells and the solid line 
represents the result of a Hill fit to these averaged data yielding an EC50 value of 44 nM (nH = 
1.1).   
 
Figure 3. In addition to KCa3.1 human microglia also have an outward-rectifying K+ current 
mediated by KCa1.1. (A) Current traces obtained from a whole-cell experiment performed as 
described in Figure 2. The traces were obtained before (1) and after application of NS309 
(500 nM; 2), and after subsequent co-application of NS309 (500 nM) and NS6180 (1 µM) 
(3). (B) Current traces from the same cell as shown in (A) and with identical trace 3. Trace 4 
was obtained upon subsequent application of the specific KCa1.1 activator NS1619 (10 µM) 
and trace 5 following co-application of NS1619 (10 µM) and Paxilline (1 µM). The time 
course of the experiment shown in (A) and (B) was analyzed at -40 mV (■, KCa3.1) as well as 
at +30 mV (○, KCa3.1 and KCa1.1) and plotted as a function of time in (C). The bars above the 
analyses indicate the periods where the different compounds were present in the extracellular 
saline and the numbers shows where the traces in panel (A) and (B) were obtained. The 
experiment is representative of n=9. 
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Figure 4. KCa3.1 currents responsive to NS309 and/or NS6180 were recorded in 79% of the 
human microglia population. Microglia cells were considered as responsive to NS309 (500 
nM) and/or NS6180 (1 µM) if the current amplitude at -40 mV changed by ≥ 20 pA in whole-
cell experiments as those described in Figure 2 and 3. (A) Time course obtained from a 
microglia cell that did not respond to NS309 (500 nM) alone nor in combination with 
NS6180 (1 µM) and which was therefore considered as a non-responder. (B) The bars show 
the number of cells that responded (n=75 equivalent to 79%) and the number of unresponsive 
cells (n=20 equivalent to 21%) as defined above. (Ci) Time course showing a representative 
experiment from a microglia cell that did respond to NS309 (500 nM) and where the current 
was inhibited by NS6180 (1 µM). (Cii) Current amplitudes from the 42 microglia cells where 
both NS309 and NS6180 were applied. The current amplitudes pre- and post-application of 
NS309 (500 nM) and after application of NS309 in combination with NS6180 (1 µM) were 
plotted with currents from individual cells connected by lines. (Di) Representative current-
clamp experiment showing a pronounced hyperpolarization upon application of NS309 (500 
nM) and a depolarization upon co-application of NS6180 (1 µM). The compounds were 
present in the extracellular saline during the periods indicated by the bars. (Dii) The 
membrane potential recorded before (Control) and after NS309 (NS309) as well as after co-
application of NS309 and NS6180 (NS309+NS6180) was plotted and data from individual 
cells (n=7) connected by lines. The average membrane potential before application of NS309 
was -24 ± 6 mV, after NS309 it was -67 ± 5 mV and after co-application of NS6180 -25 ± 5 
mV. Paired one-way ANOVA * p<0.05, *** p<0.001. 
 
Figure 5. Quantification of the KCa3.1 current in microglia activated by IL-4 or LPS. (Ai) 
Current traces obtained from voltage-clamp experiment as described in Figure 2 but from a 
microglia cell treated with IL-4 (20 ng/ml) for 4 days in vitro. The traces were obtained 
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before (Control) and after application of NS309 (500 nM) and after NS309 in combination 
with NS6180 (1 µM) as indicated at the traces. (Aii) Current amplitude at -40 mV of 
individual microglia cells pre- and post-application of NS309 and NS309 in combination with 
NS6180. (Aiii) Averages of the currents from panel Aii. Panel Bi - Biii Same as Ai-Aiii but after 
treatment with LPS (100 ng/ml). The bars in Aiii and Biii represent the mean ± SEM; paired 
one-way ANOVA * p<0.05, ** p<0.01, *** p<0.001. 
 
Figure 6. IL-4 or LPS treatment do not alter KCa3.1 current densities. (A) The bars represent 
the percentage of cells in the microglia population that express KCa3.1 channels based on the 
20 pA criterion described in Figure 4.  Microglia cultures incubated with IL-4 (20 ng/ml) or 
LPS (ng/ml) for 2-4 days in vitro do not have an altered proportion of cells expressing 
functional KCa3.1 channels compared to untreated cultures (χ2 test; p > 0.05). (B) The 
∆KCa3.1 current defined as the difference in current at -40 mV between full activation by 500 
nM NS309 and full block by 1 µM NS6180 was calculated and plotted for unstimulated and 
IL-4 as well as LPS treated cells. IL-4 treated cells show a significant increase in the ∆KCa3.1 
current compared to unstimulated cells. (C) The membrane capacitance (pF) was measured 
and plotted for unstimulated and IL-4 as well as LPS treated cells. IL-4 treated cells have a 
larger membrane area (capacitance) compared to both unstimulated and LPS treated cells. (D) 
The ∆KCa3.1 current from individual cells was divided by the membrane capacitance of the 
cell and plotted as a function of treatment. This measure of KCa3.1 current densities showed 
no significant differences between untreated and IL-4 or LPS-treated cells. Lines in B-D 
represent the mean ± SEM; unpaired one-way ANOVA ** p<0.01, *** p<0.001.  
 
Page 37 of 51
John Wiley & Sons, Inc.
GLIA
38 
 
Supplementary Figure 1. (A) IV plot showing the effect of increasing concentrations of the 
KCa3.1 activator NS309 in a HEK-293 cell stably expressing human KCa3.1 channels (Jensen 
et al. 1998). The traces were obtained upon application of voltage ramps (from -120 mV to 30 
mV in 150 ms) every 5 seconds from a holding potential of -90 mV and NS309 was present 
as indicated to the right. EK indicates the calculated reversal potential for K+ (-90 mV) with 
the salines used. (B) Time course of the experiment in (A) showing the current measured at -
40 mV as a function of time. NS309 was present in the extracellular solution as indicated by 
the bars. (C) Concentration-response plot from where an EC50 was estimated to 20 nM (nH = 
1.1) (n = 6) as described in legend to Fig. 2D. The data points represent the mean ± SD. The 
experiments were performed using the same experimental conditions, voltage-ramp protocol 
and the same saline solutions (~1 µM free Ca2+) as for the microglia experiments.  
 
Supplementary Figure 2. Human microglia express voltage-independent KCa3.1 channels in 
addition to both outward- and inward-rectifying K+ channels. (A) Semi-
quantitative/qualitative non-pharmacological (Kir and Kor) and pharmacological (KCa3.1) 
analysis of the distribution and combination of K+ channels within the microglia population. 
There is no difference in the proportion of cells expressing (B) inward-rectifying K+ (Kir) or 
(C) outward-rectifying K+ (Kor) expression in activated microglia compared to unstimulated 
cells (Kir: χ2 test = 0.07; Kor: χ2 test = 0.055). Bars in B-C represent the percentage of the 
microglia population that express Kir or Kor irrespective of the other K+ channels. 
 
Supplementary Figure 3. Electrophysiological whole-cell recording of a rat microglia cell 
using identical electrophysiology protocol and salines as for the human microglia 
experiments. Mixed glia cell cultures were generated from rat pup brains according to 
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standard procedures and were allowed to recover in culture for 14 days. The microglia were 
subsequently isolated from the confluent astrocyte layer by shaking followed by plating in 
petri dishes containing glass coverslips for electrophysiological recordings. The trace was 
obtained upon application of voltage ramps (from -120 mV to 30 mV in 150 ms) every 5 
seconds from a holding potential of -90 mV. EK indicates the calculated reversal potential for 
K+ (-90 mV) with the salines used.  
 
Supplementary Figure 4. IV plot of a human microglia cell before (Control) and post-
application NS309 (500 nM) in combination with NS6180 (1 µM). The Kir expression is seen 
more clearly when the KCa3.1 current has been fully inhibited by NS6180.  
 
Supplementary Figure 5. The KCa3.1 current amplitude in human microglia does not change 
over the time in culture. (A) Baseline, NS309-induced and ∆KCa3.1 current amplitude in 
unstimulated cells from day 5 (earliest experimental day) to day 9 (last experimental day) 
post-isolation. (B-C) Baseline, NS309 and ∆KCa3.1 current amplitude in IL-4 (20 ng/ml, B) 
and LPS (100 ng/ml, C) treated cells after 2, 3 or 4 days of stimulation. The incubation with 
IL-4 and LPS was started after 5 days in culture. No difference in the KCa3.1 current 
amplitude was observed over the length of the stimulation. Lines represent the mean ± SEM; 
unpaired one-way ANOVA p>0.05.   
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Figure 1. The human microglia culture is pure and responsive to stimulation with LPS. Photomicrographs of 
the cell culture with (A) human microglia stained for Iba1 in red and (B) astrocytes stained for GFAP in 
green 6 days post-isolation. The boxes in the bottom right corners show a microglia and an astrocyte, 
respectively, at higher magnification. Counterstaining of DAPI+ nuclei can be seen in blue. A-B (including 
insert): Scale bars: 50 µm. (C) Quantitative purity analysis of the human microglia cultures (n = 3) at 6 
days post-isolation. In addition to Iba1 and GFAP the cultures were stained for neurons (MAP2) and 
oligodendrocytes (CC-1) and stained cells were expressed as a percentage of the total amount of DAPI+ 
nuclei. (D) Quantification of TNF-α release following incubation with LPS (0.3, 1, and 10 ng/ml) for four 
hours shows a significant response at all LPS concentrations tested. C-D: Bars represent mean ± SEM; D: 
unpaired one-way ANOVA ** p<0.01, *** p<0.001. (E) Gene expression analysis of pro-inflammatory 
cytokines following stimulation with LPS for four hours. Bars represent mean ± SEM; unpaired t-test * 
p<0.05, ** p<0.01.  
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Figure 2. Human microglia express KCa3.1 channels sensitive to the inhibitor NS6180 and the activator 
NS309. (A) Current-voltage (IV) plot from a human microglia cell obtained during a whole-cell recording in 
voltage-clamp mode. The currents were elicited by applying voltage ramps (from -120 mV to 30 mV in 150 
ms) every 5 seconds from a holding potential of -90 mV. The current traces appear voltage-independent 
(linear) and were obtained before (Control) and after the application of the KCa3.1 selective inhibitor NS6180 
(1 µM). The KCa3.1 IV curve (red trace) was obtained by subtracting the NS6180 trace from the Control 
trace. EK indicates the calculated equilibrium potential for K+ (-90 mV) with the salines used (see method 
section). (B) IV plot showing the effect of increasing concentrations of the KCa3.1 activator NS309. The 
individual current traces were obtained before or after application of NS309 in the concentrations indicated 
to the right of the traces. (C) Time course of the experiment in (B) plotted as the current amplitude 
measured at -40 mV as a function of time. NS309 was present in the extracellular saline as indicated by the 
bars. (D) Averaged concentration-response plot for NS309. For each cell (n=7) the responses to NS309 
were fitted to a Hill equation (EC50 values in the individual cells ranged from 16 to 85 nM) and normalized to 
the fitted current maxima. These normalized data points were averaged and plotted in (D) where each point 
represent the mean ± SD from 4-5 cells and the solid line represents the result of a Hill fit to these 
averaged data yielding an EC50 value of 44 nM (nH = 1.1).    
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Figure 3. In addition to KCa3.1 human microglia also have an outward-rectifying K+ current mediated by 
KCa1.1. (A) Current traces obtained from a whole-cell experiment performed as described in Figure 2. The 
traces were obtained before (1) and after application of NS309 (500 nM; 2), and after subsequent co-
application of NS309 (500 nM) and NS6180 (1 µM) (3). (B) Current traces from the same cell as shown in 
(A) and with identical trace 3. Trace 4 was obtained upon subsequent application of the specific KCa1.1 
activator NS1619 (10 µM) and trace 5 following co-application of NS1619 (10 µM) and Paxilline (1 µM). The 
time course of the experiment shown in (A) and (B) was analyzed at -40 mV (■, KCa3.1) as well as at +30 
mV (○, KCa3.1 and KCa1.1) and plotted as a function of time in (C). The bars above the analyses indicate the 
periods where the different compounds were present in the extracellular saline and the numbers shows 
where the traces in panel (A) and (B) were obtained. The experiment is representative of n=9.  
Fig. 3  
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Figure 4. KCa3.1 currents responsive to NS309 and/or NS6180 were recorded in 79% of the human 
microglia population. Microglia cells were considered as responsive to NS309 (500 nM) and/or NS6180 (1 
µM) if the current amplitude at -40 mV changed by ≥ 20 pA in whole-cell experiments as those described in 
Figure 2 and 3. (A) Time course obtained from a microglia cell that did not respond to NS309 (500 nM) 
alone nor in combination with NS6180 (1 µM) and which was therefore considered as a non-responder. (B) 
The bars show the number of cells that responded (n=75 equivalent to 79%) and the number of 
unresponsive cells (n=20 equivalent to 21%) as defined above. (Ci) Time course showing a representative 
experiment from a microglia cell that did respond to NS309 (500 nM) and where the current was inhibited 
by NS6180 (1 µM). (Cii) Current amplitudes from the 42 microglia cells where both NS309 and NS6180 were 
applied. The current amplitudes pre- and post-application of NS309 (500 nM) and after application of NS309 
in combination with NS6180 (1 µM) were plotted with currents from individual cells connected by lines. (Di) 
Representative current-clamp experiment showing a pronounced hyperpolarization upon application of 
NS309 (500 nM) and a depolarization upon co-application of NS6180 (1 µM). The compounds were present 
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before (Control) and after NS309 (NS309) as well as after co-application of NS309 and NS6180 
(NS309+NS6180) was plotted and data from individual cells (n=7) connected by lines. The average 
membrane potential before application of NS309 was -24 ± 6 mV, after NS309 it was -67 ± 5 mV and after 
co-application of NS6180 -25 ± 5 mV. Paired one-way ANOVA * p<0.05, *** p<0.001.  
Fig. 4  
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Figure 5. Quantification of the KCa3.1 current in microglia activated by IL-4 or LPS. (Ai) Current traces 
obtained from voltage-clamp experiment as described in Figure 2 but from a microglia cell treated with IL-4 
(20 ng/ml) for 4 days in vitro. The traces were obtained before (Control) and after application of NS309 
(500 nM) and after NS309 in combination with NS6180 (1 µM) as indicated at the traces. (Aii) Current 
amplitude at -40 mV of individual microglia cells pre- and post-application of NS309 and NS309 in 
combination with NS6180. (Aiii) Averages of the currents from panel Aii. Panel Bi - Biii same as Ai-Aiii but after 
treatment with LPS (100 ng/ml). The bars in Aiii and Biii represent the mean ± SEM; paired one-way ANOVA 
* p<0.05, ** p<0.01, *** p<0.001.  
Fig. 5  
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Figure 6. IL-4 or LPS treatment do not alter KCa3.1 current densities. (A) The bars represent the percentage 
of cells in the microglia population that express KCa3.1 channels based on the 20 pA criterion described in 
Figure 4. Microglia cultures incubated with IL-4 (20 ng/ml) or LPS (ng/ml) for 2-4 days in vitro do not have 
an altered proportion of cells expressing functional KCa3.1 channels compared to untreated cultures (χ2 test; 
p > 0.05). (B) The ∆KCa3.1 current defined as the difference in current at -40 mV between full activation by 
500 nM NS309 and full block by 1 µM NS6180 was calculated and plotted for unstimulated and IL-4 as well 
as LPS treated cells. IL-4 treated cells show a significant increase in the ∆KCa3.1 current compared to 
unstimulated cells. (C) The membrane capacitance (pF) was measured and plotted for unstimulated and IL-4 
as well as LPS treated cells. IL-4 treated cells have a larger membrane area (capacitance) compared to both 
unstimulated and LPS treated cells. (D) The ∆KCa3.1 current from individual cells was divided by the 
membrane capacitance of the cell and plotted as a function of treatment. This measure of KCa3.1 current 
densities showed no significant differences between untreated and IL-4 or LPS-treated cells. Lines in B-D 
represent the mean ± SEM; unpaired one-way ANOVA ** p<0.01, *** p<0.001.  
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Supplementary Figure 1. (A) IV plot showing the effect of increasing concentrations of the KCa3.1 
activator NS309 in a HEK-293 cell stably expressing human KCa3.1 channels (Jensen et al. 1998). The traces 
were obtained upon application of voltage ramps (from -120 mV to 30 mV in 150 ms) every 5 seconds from 
a holding potential of -90 mV and NS309 was present as indicated to the right. EK indicates the calculated 
reversal potential for K+ (-90 mV) with the salines used. (B) Time course of the experiment in (A) showing 
the current measured at -40 mV as a function of time. NS309 was present in the extracellular solution as 
indicated by the bars. (C) Concentration-response plot from where an EC50 was estimated to 20 nM (nH = 
1.1) (n = 6) as described in legend to Fig. 2D. The data points represent the mean ± SD. The experiments 
were performed using the same experimental conditions, voltage-ramp protocol and the same saline 
solutions (~1 µM free Ca2+) as for the microglia experiments.  
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Supplementary Figure 2. Human microglia express voltage-independent KCa3.1 channels in addition to 
both outward- and inward-rectifying K+ channels. (A) Semi-quantitative/qualitative non-pharmacological (Kir 
and Kor) and pharmacological (KCa3.1) analysis of the distribution and combination of K+ channels within the 
microglia population. There is no difference in the proportion of cells expressing (B) inward-rectifying K+ (Kir) 
or (C) outward-rectifying K+ (Kor) expression in activated microglia compared to unstimulated cells (Kir: χ2 
test = 0.07; Kor: χ2 test = 0.055). Bars in B-C represent the percentage of the microglia population that 
express Kir or Kor irrespective of the other K+ channels.  
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Supplementary Figure 3. Electrophysiological whole-cell recording of a rat microglia cell using identical 
electrophysiology protocol and salines as for the human microglia experiments. Mixed glia cell cultures were 
generated from rat pup brains according to standard procedures and were allowed to recover in culture for 
14 days. The microglia were subsequently isolated from the confluent astrocyte layer by shaking followed by 
plating in petri dishes containing glass coverslips for electrophysiological recordings. The trace was obtained 
upon application of voltage ramps (from -120 mV to 30 mV in 150 ms) every 5 seconds from a holding 
potential of -90 mV. EK indicates the calculated reversal potential for K+ (-90 mV) with the salines used.  
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Supplementary Figure 4. IV plot of a human microglia cell before (Control) and post-application NS309 
(500 nM) in combination with NS6180 (1 µM). The Kir expression is seen more clearly when the KCa3.1 
current has been fully inhibited by NS6180.  
 
75x60mm (300 x 300 DPI)  
 
 
Page 51 of 51
John Wiley & Sons, Inc.
GLIA
  
 
 
Supplementary Figure 5. The KCa3.1 current amplitude in human microglia does not change over the time 
in culture. (A) Baseline, NS309-induced and ∆KCa3.1 current amplitude in unstimulated cells from day 5 
(earliest experimental day) to day 9 (last experimental day) post-isolation. (B-C) Baseline, NS309 and 
∆KCa3.1 current amplitude in IL-4 (20 ng/ml, B) and LPS (100 ng/ml, C) treated cells after 2, 3 or 4 days of 
stimulation. The incubation with IL-4 and LPS was started after 5 days in culture. No difference in the KCa3.1 
current amplitude was observed over the length of the stimulation. Lines represent the mean ± SEM; 
unpaired one-way ANOVA p>0.05.  
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